Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer

Alice Blondel (1) , Amine Benberghout (1) , Remy Pedeux (1) , Charles Ricordel (1, 2)

1 COSS - Chemistry, Oncogenesis, Stress and Signaling
2 CHU Pontchaillou [Rennes]

Keywords: HDAC inhibitors; ING2; ING1; ING3; ING4; ING5; NSCLC; chromatin remodeling; mSin3A/HDAC complex; therapeutic approach; non-small cell lung cancer

Domains: Life Sciences [q-bio]; Cancer

Alice Blondel, Amine Benberghout, Remy Pedeux, Charles Ricordel. Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer. Cancers, 2019, 11 (10), pp.E1601. ⟨10.3390/cancers11101601⟩. ⟨hal-02365418⟩